Investors

Expedeon Expands UK Facility & Increases Laboratory Space

Expedeon Expands UK Facility & Increases Laboratory Space

Cambridge, UK, 25 April 2016: Expedeon (Innova), a specialist provider of bioconjugation products and services, today announced it has expanded its UK footprint to enable the company to increase its laboratory space.

Innova’s sales and marketing teams have moved from the Babraham Research Park to Ashwell Point in Sawston, accommodating another 2500 sq ft of office space to double the company’s footprint across the two sites. The move enables both extra laboratory and office space to allow for further growth as the company continues to expand.

Expedeon are world leading experts in easy-to-use, cutting-edge bioconjugation technologies and services, with the flexibility to support scientists from academia through to commercial manufacturing. Products are based on its antibody and protein labeling, nanoparticle, oligonucleotide labeling, and phosphate detection enzyme assay technologies. The move marks the next stage in the Company’s development, and comes in response to increasing demand for its products and services.

Dr Nick Gee, CEO of Expedeon, commented: “Innova has expanded its laboratory space to accommodate the need for increased and continuous development of new products based on our bioconjugation technology, in addition to the custom services offering which has also grown year on year.” ENDS